Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.610
-0.020 (-3.17%)
At close: Apr 28, 2026, 4:00 PM EDT
0.604
-0.006 (-0.95%)
After-hours: Apr 28, 2026, 4:45 PM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $24.92 million as of April 28, 2026. Its market cap has decreased by -9.82% in one year.
Market Cap
24.92M
Enterprise Value
-34.26M
1-Year Change
-9.82%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $24.92M, a decrease of -95.70%. That is a compound annual growth rate of -46.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 25.73M | -9.97% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 27.57M |
| NanoViricides | 26.99M |
| ABVC BioPharma | 26.69M |
| NeuroSense Therapeutics | 26.53M |
| CEL-SCI | 26.38M |
| Longeveron | 26.35M |
| AEON Biopharma | 26.32M |
| Quantum BioPharma | 26.07M |